In persons with a chronic medical disease, depression often makes the management of chronic illness more difficult. Recently, vitamin D has been reported in the scientific and lay press as an important factor that may have significant health benefits in the prevention and the treatment of many chronic illnesses. Whether this is due to insufficient dietary intake, lifestyle (e.g., little outdoor exposure to sunshine), or other factors is addressed in this paper. In addition, groups at risk and suggested treatment for inadequate vitamin D levels are addressed. Effective detection and treatment of inadequate vitamin D levels in persons with depression and other mental disorders may be an easy and cost-effective therapy which could improve patients’ long-term health outcomes as well as their quality of life.
The mechanism whereby vitamin D may be associated with mental disorders is not clearly understood. It has been reported that there are vitamin D receptors in the hypothalamus, which may be important in neuroendocrine functioning.
There has been research examining the relationship of vitamin D to seasonal affective disorder (SAD), schizophrenia, and depression. Several studies have examined whether light therapy improved mood.
Partonen, Vakkuri, Lamberg-Allardt, and Lonnqvist (1996) randomized 29 patients (16 with SAD and 13 controls) in a parallel fashion to either one hour or 15 minutes of light therapy in the morning for two weeks in the winter. One hour of light therapy significantly decreased depressive symptoms more so in the group with SAD than the control group (
p = .003).
Gloth, Alam, and Hollis (1999) randomized 15 participants with SAD to either 100,000 IU of vitamin D (one time dose) (
n = 8) or phototherapy (
n = 7). They reported that depression (assessed with the Hamilton Depression Scale) decreased in persons who received vitamin D (from 10.9 to 6.2,
p = .040) as compared to those who received phototherapy (from 12.6 to 11.3,
p = ns). There were no untoward side effects from the dose of vitamin D; however, a limitation of the study was the one time dose.
Studies have examined the relationship of vitamin D to other psychiatric disorders. In a prospective birth cohort that studied the intake of vitamin D supplements in the first year of life, it was noted that an intake of 2,000 IU or more per day was associated with a reduced risk of developing schizophrenia (RR = 0.23, CI = .06–.95) for males. The limitations of the study were that although there was a large sample (over 9,114 persons), the number of individuals with schizophrenia was small (
n = 79) (
McGrath et al., 2004). In addition, exposure to vitamin D was based on the mother’s self-report in the first year of life. Lower levels of vitamin D have been noted with other mental disorders.
Schneider, Weber, Frensch, Stein, and Fritze (2000) reported that vitamin D levels were lower in persons with schizophrenia (Mean = 35.1 pg/ml) and major depression (37.3) when compared to healthy controls (45.9). However, the difference was lower only for those with schizophrenia when compared to the controls.